newsfilter
← Latest News
GlobeNewswire·

Ambrx to be Added to the NASDAQ Biotechnology Index (NBI)

SAN DIEGO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., or Ambrx, (NASDAQ:AMAM), today announced that the Company will be added to the NASDAQ Biotechnology Index (NASDAQ:NBI), effective prior to the market